跳轉至內容
Merck
  • Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.

Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.

Neurobiology of disease (2020-02-08)
Nikhita Anand, Angelina Holcom, Michael Broussalian, Minna Schmidt, Shankar J Chinta, Gordon J Lithgow, Julie K Andersen, Manish Chamoli
摘要

Mutations in the human ATP13A2 gene are associated with an early-onset form of Parkinson's disease (PD) known as Kufor Rakeb Syndrome (KRS). Patients with KRS show increased iron deposition in the basal ganglia, suggesting iron toxicity-induced neurodegeneration as a potential pathogenesis associated with the ATP13A2 mutation. Previously we demonstrated that functional losses of ATP13A2 disrupt the lysosomes ability to store excess iron, leading to reduce survival of dopaminergic neuronal cells. To understand the possible mechanisms involved, we studied a Caenorhabditis elegans mutant defective in catp-6 function, an ortholog of human ATP13A2 gene. Here we show that catp-6 mutant worms have defective autophagy and lysosomal function, demonstrate characteristic PD phenotypes including reduced motor function and dysregulated iron metabolism. Additionally, these mutants have defective mitochondrial health, which is rescuable via iron chelation or mitophagy induction.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
羰基氰化物 4-(三氟甲氧基)苯腙, ≥98% (TLC), powder
Sigma-Aldrich
柠檬酸三铵, ≥97% (titration)
Sigma-Aldrich
Anti-γ-Tubulin (LL-17) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution